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Background: Long chain polyunsaturated fatty acids (LCPUFAs) are biologically active fatty acids which regulate
placental angiogenesis, inﬂammation, and oxidative stress. Abnormalities in these aspects have been associated
with preeclampsia (PE). Further, placenta has a heterogeneous structure with differential vascularization across
different regions.We therefore hypothesize that the distribution of fatty acids in various regions of the placenta is
altered in PE leading to poor fetal outcome.
Methods: In this cross-sectional study we recruited 69 normotensive control (NC) and 44 women with PE. PE
women were further classiﬁed as those delivered preterm (PTPE, n = 24) and at term (TPE, n = 20). Fatty
acid levels were analyzed from placental samples from four different regions (CF—central fetal, PF—peripheral
fetal, CM—central maternal and PM—peripheral maternal).
Results: In the NC placenta, AA levels were lower (p b 0.05) in CM as compared with CF region. However, such
differences were not seen in the TPE and PTPE. In contrast, the DHA levels varied between regions only in the
PTPE placenta. Between groups, DHA levels were lower (p b 0.05 for both) in the CM and CF regions of the
PTPE as compared with NC. The levels of DHA in TPE placenta were similar to NC. AA levels were lower
(p b 0.05 for both) in CF region of TPE and PF region of PTPE placenta than NC.
Conclusions: There is differential pattern of LCPUFA distribution across various regions of the NC, TPE and PTPE
placenta. This may have implications for placental growth and development as well as transfer of LCPUFA to
the fetus.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Preeclampsia (PE) is a pregnancy induced hypertensive disorder
which manifests after 20 weeks of gestation and till date its etiology is
not well understood [1]. A number of placental abnormalities have
been associated with PE pregnancies, such as insufﬁcient spiral artery
remodeling, shallow invasion, and reduced villous number, diameter
and surface area. Placental function gets affected by these abnormalities,
and ultimately deprives the developing fetus of the nutrients required
for optimal growth [2,3]. Nutrients like fatty acids are not only required
by the developing fetus but also metabolized by the placenta for its
growth and development [4].
Fatty acids especially long chain polyunsaturated fatty acids
(LCPUFAs) are biologically active fatty acids which have been found to
be associated with a number of developmental and functional aspects
of the placenta. LCPUFAs are required by the placenta for membrane
synthesis and tomaintain ﬂuidity for intercellular signaling [5]. Further,ne, Interactive Research School
, Pune 411043, MH, India.
utam).
. This is an open access article underLCPUFAs act as ligands for transcription factors which regulate genes in-
volved in trophoblast proliferation and differentiation [6]. Our earlier
studies on women with PE report altered placental LCPUFA levels, dis-
turbed angiogenesis and fatty acid transport in the maternal region of
the placenta [7,8]. It is well known that the morphological heterogene-
ity of the placenta comprises of both fetal and maternal tissues [9–11].
Differences in vascularisation across the placenta resulting in differ-
ences of oxygen availability are also reported within the placenta [12,
13]. Several studies have reported gradients in protein levels, gene ex-
pression and enzyme activities across the normal placenta [14–18].
Therefore, there could be functional specialization of different regions
of the placenta which requires extensive research.
PE has also been associated with increased oxidative stress and in-
ﬂammation originating from the placenta and affecting both mother
and the fetus [19,20]. LCPUFA can form active metabolites like eicosa-
noids, resolvins and protectins which regulates inﬂammation and it
can also reduce oxidative damage in the trophoblast cells [21]. In the
presence of reactive oxygen species, LCPUFA get per-oxidized into
malondialdehyde (MDA) which is an oxidative stress marker [22].
Recently we have shown increased levels of MDA and decreased levels
of catalase an antioxidant enzyme in a region speciﬁc manner in thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Sampling sites of the placenta. CM — central maternal region, PM — peripheral
maternal region, CF— central fetal region, PF — peripheral fetal region.
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ations in the inﬂammatory cytokines, nitric oxide synthase enzyme
and heat shock proteins in the PE placenta [20,24–26].
It is likely that the LCPUFAmetabolismmay differ in the placenta de-
pending upon the requirement by the trophoblast cells for different
physiological processes.We therefore hypothesize that the regional dis-
tribution of fatty acids in the placenta is altered in preeclampsia leading
to poor birth outcome. In the current study we examined the levels of
fatty acid in various regions of the PE and normotensive control (NC)
placenta and compared the levels within and between groups. Further,
the associations of LCPUFA levels with birth weight and blood pressure
were studied.
2. Materials and methods
2.1. Study participants
This is a cross-sectional study where pregnant women were
recruited at Department of Obstetrics and Gynecology of Bharati
Hospital, Pune, India. This study was ethically approved by the Bharati
Vidyapeeth Medical College Institutional Ethical Committee, Pune,
India. Written informed consents were taken from each participant.
Maternal weight and height were taken at the time of recruitment
for the calculate body mass index (BMI). A total of 69 normotensive
pregnant women delivering at term (gestation ≥ 37 weeks, baby
weight ≥ 2.5 kg) and 44 pregnant women with PE were recruited for
the study. PE was deﬁned by systolic BP and diastolic BP N140 and
90 mm Hg (repeated measures by Mercury sphygmomanometer) re-
spectively and the presence of proteinuria (N1+ or 300 mg per 24 h,
by Dipstick test). The detailed exclusion and inclusion criteria were as
described by us earlier [23]. The PE cases were further divided into 24
preterm PE (PTPE) and 20 term PE (TPE) after delivery. Baby birth
weight was measured using a digital weighing scale (Zeal Medical
Private Limited, India) with 10 g accuracy. Baby length was measured
using a portable infantometer.
2.2. Placental sampling
Placenta was collected in 1X phosphate buffer saline (PBS) immedi-
ately following delivery. Small pieces of fresh tissues were collected
from four different sites of the placenta after removing the fetal mem-
brane as described in our recent study [23]. Velamentous cord insertion
cases were excluded from the study. Brieﬂy, four sampling sites were
selected 1) CM (central maternal) — small pieces (~1 cm2) of basal
plate villous tissue were cut out from the normal appearing cotyledons
around the cord insertion avoiding blood clots and infarcts, 2) PM
(peripheral maternal) — from peripheral cotyledons of the basal plate
farthest from the cord insertion and 1 cm away from the lateral edge of
the placental disk, similarly 3) CF (central fetal)— fromcentral cotyledons
of the chorionic plate and 4) PF (peripheral fetal)— from peripheral cot-
yledons of the chorionic plate (Fig. 1). Excess blood was washed off with
1X PBS and then the samples were stored at−80 °C till further analyzed.
2.3. Fatty acid analysis
The fatty acid estimation procedure followed for analysis was as
reported in series of our earlier studies [7,27]. Brieﬂy, placental tissue
was homogenized with chilled lysis buffer and ultra-centrifuged.
Transesteriﬁcation of fatty acids present in the cell membrane fraction
was done using methanolic–hydrochloric acid. These fatty acid methyl
esters (FAMEs)were analyzed using a Perkin Elmer Gas Chromatograph
at our standardized settings (SP 2330, 30 m capillary Supelco column).
A mixture of standard fatty acid methyl esters (Sigma) was used to
identify 15 important fatty acids by retention time. The relative FAME
amounts were expressed as g/100 g fatty acid (% total fatty acids).
Fatty acids were categorized into total omega 6 fatty acids (omega 6):summation of linoleic acid (LA), gamma linolenic acid, dihomo
gamma linolenic acid, docosapentaenoic acid and arachidonic acid
(AA); total omega 3 fatty acids (omega 3): summation of alpha
linolenic acid (ALA), eicosapentaenoic acid and docosahexaenoic
acid (DHA); saturated fatty acids (SFAs): summation of myristic acid,
palmitic acid and stearic acid; and monounsaturated fatty acids
(MUFAs): summation of myristoleic acid, palmitoleic acid, oleic acid
and nervonic acid.
2.4. Statistical analysis
The sample size was calculated based on our earlier study taking the
mean difference of placental DHA levels between the case and the
control [7]. It was done using PS sample size calculator software (ver.
3.0.43) with 80% power of the study, 0.05 type I error probability and
3 control subjects per case. Hence, 69 controls and around 23 cases in
each PE group were included in this study.
The data was analyzed using the SPSS/PC+ package (Version 20,
Chicago, IL, USA). Values are reported as Mean ± Standard Deviation
(S.D.). Skewed variables were normalized using the log10 transforma-
tion. Means were compared using one way ANOVA. Associations with
birth weight and BP were performed using Pearson's partial correlation
after adjusting for confounder i.e. gestational age, maternal age and BMI
in NC and PE as separate groups. It was also done for whole cohort
after adjusting for groups. Results were considered signiﬁcant when
p b 0.05.
3. Results
3.1. Maternal and neonatal characteristics
The systolic BP and diastolic BP of both PTPE and TPE women were
higher (p b 0.01 for all) as compared with NC women. PTPE women
had even higher systolic BP and diastolic BP (p b 0.01 for both) as com-
pared with TPE women. BMIs of both the TPE (p b 0.01) and PTPE
(p b 0.05) women were higher as compared with NC women.
In PTPE and TPE groups, birth weight and baby length were lower
(p b 0.01 for all) as compared with NC group. These birth measures
were even lower (p b 0.01 for both) in PTPE as compared with TPE
group (Table 1).
3.2. Comparison of fatty acid levels across different placental regionswithin
normotensive control, preterm-preeclampsia and term-preeclampsia
In the NC group, no differences were observed in the levels of LA
within the placenta. However, AA levels were higher (p b 0.05 for
Table 1
Maternal and neonatal demographic characteristics.
Groups NC (n = 69) TPE (n = 20) PTPE (n = 24)
Maternal age (Yr) 24.38 ± 3.47 25.24 ± 3.62 27.26 ± 4.87**,&&
Income (Rs) 11,303.03 ± 7749.88 15,700 ± 12,260.76** 10,673.91 ± 7612.20&&
BMI (kg/m2) 24.91 ± 4.07 29.35 ± 4.68** 27.18 ± 5.35*
Sys BP (mm Hg) 119.19 ± 8.27 151.90 ± 18.06** 155.74 ± 19.67**,&&
Dias BP (mm Hg) 77.04 ± 5.19 94.86 ± 10.31** 100.87 ± 11.31**,&&
Gestation (weeks) 38.86 ± 1.14 38.49 ± 1.43 34.07 ± 2.13**,&&
Parity (%)
Nulliparous 40.3 55 33.3
Multiparous 59.7 45 66.7
Education (%)
Illiterate 8.7 5 0
Lower 39.1 45 41.6
Higher 17.4 25 25
Graduation 31.9 25 29.2
Post graduation 2.9 0 4.2
MOD (n)
Vaginal 56 9 4
C-section 13 11 20
Birth weight (kg) 2.90 ± 0.31 2.62 ± 0.57** 1.70 ± 0.44**,&&
Baby length (cm) 49.30 ± 3.14 47.48 ± 2.87** 42.21 ± 3.68**,&&
Baby sex (n)
Male 40 9 19
Female 29 11 5
NC — normotensive control, TPE — term preeclampsia; PTPE — preterm preeclampsia; BMI — body mass index; Sys BP — systolic blood pressure; Dias BP — diastolic blood pressure;
Education: Lower —grades 1 to 10, Higher —grades 11 to 12 or intermediate; MOD — mode of delivery; C-section — cesarean delivery; n — number; *p b 0.05; **p b 0.01 as compared
with NC, &&p b 0.01 as compared with TPE. Data represented as Mean ± S.D.
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fatty acid levels were higher (p b 0.05 and p b 0.01 respectively) in
the PF region as compared with the PM and CM regions. There were
no signiﬁcant regional differences in the levels of ALA, DHA, omega 3
fatty acid, omega 6:omega 3 and SFA. Further, MUFA levels were
lower (p b 0.01 and p b 0.05 respectively) in the CF and PF regions as
compared with the CM region.
In the PTPE group, no regional differences were observed in any of
the omega 6 fatty acid levels. DHA, omega 3 fatty acid and MUFA levels
were lower (p b 0.05 for all) in the CF region as compared with the PM
region. Omega 6:omega 3 fatty acid ratio was higher (p b 0.01 and
p b 0.05 respectively) in the CF region as compared with the PM and
PF regions. SFA levels were higher (p b 0.05) in the CM as compared
with the PM region.
In the TPE group, no regional differenceswere observed in any of the
fatty acid levels within the placenta. All the results are represented in
Table 2.
3.3. Comparison of placental fatty acid levels between normotensive
control, preterm-preeclampsia and term-preeclampsia groups
WhenPTPE placentawas comparedwithNCplacenta, LA levelswere
similar in both the groups in all the four regions. AA and omega 6 fatty
acid levels were lower (p b 0.05 for both) in the PF region. ALA levels
were higher (p b 0.05 for both) in CF and PF regions. In contrast, DHA
levels were lower (p b 0.01 and p b 0.05 respectively) in CM and CF re-
gions. Similarly, omega 3 fatty acid levels were lower (p b 0.05 for both)
in CM and CF regions. Omega 6:omega 3 fatty acid ratio was higher
(p b 0.05) in CF region and similar trend (p = 0.05) was there in the
CM region. SFA levels were higher in CM and PF (p b 0.01 for both)
regions.
When TPE placenta was compared with the NC placenta, AA
levels were lower (p b 0.05) in the CF region. SFA levels were higher
(p b 0.05 and p b 0.01 respectively) in PM and PF regions. Other fatty
acids did not show any difference between the two groups.
When PTPE placenta was compared with TPE placenta, DHA levels
were lower (p b 0.05 for all) in CM, CF and PF regions. Omega 3 fatty
acid levels were lower (p b 0.05 and p b 0.01 respectively) in CM and
CF regions. ALA, LA, AA and omega 6 fatty acid did not show anydifference between the two groups. Omega 6:omega 3 fatty acid ratio
was higher (p b 0.05 and p b 0.01 respectively) in CM and CF regions.
MUFA and SFA levels did not show any signiﬁcant differences. All the
results are represented in Table 2.
3.4. Regionwise association of LCPUFAwith birth weight and blood pressure
DHA of PF region was positively (n= 39, r = 0.35, p = 0.035) asso-
ciated with birth weight in the PE group (combining TPE and PTPE) and
showed similar trend (n= 94, r = 0.2, p = 0.053) in the whole cohort.
Omega 6 fatty acid of CF regionwas positively (n=54, r=0.29, p=
0.037) associatedwithmaternal systolic BP in theNCgroup and showed
similar correlation (n = 93, r = 0.25, p = 0.019) in the whole cohort.
Omega 6 fatty acid of PF region was positively (n = 39, r = 0.36, p =
0.032) associatedwithmaternal systolic BP in the PE group and showed
similar correlation (n = 93, r = 0.22, p = 0.042) in the whole cohort.
4. Discussion
To the best of our knowledge this study for the ﬁrst time demon-
strates regional fatty acid distribution in the normotensive and pre-
eclampsia placenta. We have observed differential regional fatty acid
distribution in both NC and PE placenta. Important ﬁndings of this
study within groups are (1) AA levels were higher in CF region as com-
pared to CM region of the placenta only in NC. (2) Omega 6:omega 3
fatty acid ratio was higher in the CF region as compared to PF region
of the placenta only in PTPE.
Analysis of the data between groups indicates that (1) ALA levels
were higher in both the fetal regions (CF & PF) of the placenta in the
PTPE as comparedwith NC. However, DHA and omega 3 fatty acid levels
were lower in both the central regions (CM&CF) of the placenta in PTPE
as comparedwithNC and TPE. (2) AA and omega 6 fatty acid levelswere
lower in the PF region of the placenta in PTPE as compared with NC.
(3) SFA levels were higher in PF region of the placenta in TPE and
PTPE as compared with NC. (4) DHA of PF region was positively associ-
ated with baby birth weight in overall PE group. (5) Omega 6 fatty acid
of the fetal regions (CF and PF) was positively associated with maternal
systolic BP in whole cohort.
Table 2
Regionwise fatty acid levels in normotensive control and preeclampsia placenta.
Fatty acids (g/100 g fatty acids) Groups CM CF PM PF
LA NC 10.22 ± 2.11 9.79 ± 2.47 9.90 ± 2.23 10.16 ± 2.59
TPE 9.39 ± 2.73 10.34 ± 2.18 9.69 ± 2.16 10.27 ± 2.64
PTPE 9.92 ± 2.21 9.86 ± 2.15 10.40 ± 1.98 10.40 ± 1.86
AA NC 23.04 ± 4.76 24.80 ± 4.80@ 23.52 ± 5.43 24.76 ± 5.03@
TPE 22.97 ± 3.65 22.37 ± 2.83* 22.22 ± 3.79 22.82 ± 4.55
PTPE 21.78 ± 5.19 24.17 ± 5.48 22.60 ± 4.53 22.33 ± 4.67*
Omega 6 NC 37.42 ± 4.20 38.73 ± 3.44 37.48 ± 4.72 39.22 ± 3.68@@,%
TPE 36.55 ± 3.05 37.33 ± 2.31 36.21 ± 3.91 37.63 ± 4.57
PTPE 35.69 ± 4.72 37.99 ± 5.23 37.28 ± 3.66 36.93 ± 3.93*
ALA NC 0.17 ± 0.15 0.15 ± 0.10 0.15 ± 0.12 0.18 ± 0.35
TPE 0.23 ± 0.23 0.18 ± 0.10 0.20 ± 0.16 0.17 ± 0.14
PTPE 0.24 ± 0.16 0.21 ± 0.13* 0.19 ± 0.12 0.22 ± 0.13*
DHA NC 1.94 ± 0.73 1.80 ± 0.75 1.99 ± 0.87 1.85 ± 0.65
TPE 1.85 ± 0.74 2.01 ± 0.69 1.97 ± 0.90 2.00 ± 0.78
PTPE 1.44 ± 0.75**,& 1.43 ± 0.82*,& 1.80 ± 0.77# 1.60 ± 0.54&
Omega 3 NC 2.28 ± 0.70 2.13 ± 0.74 2.31 ± 0.84 2.23 ± 0.78
TPE 2.27 ± 0.67 2.40 ± 0.65 2.31 ± 0.91 2.38 ± 0.79
PTPE 1.88 ± 0.74*,& 1.80 ± 0.84*,&& 2.21 ± 0.72# 2.08 ± 0.72
Omega 6:omega 3 NC 18.20 ± 6.71 20.54 ± 7.67 18.41 ± 7.18 19.76 ± 7.32
TPE 17.26 ± 4.38 16.93 ± 6.00 18.97 ± 11.07 17.84 ± 6.85
PTPE 21.04 ± 6.30& 25.01 ± 11.96*,&& 18.72 ± 6.90## 19.09 ± 4.61#
SFA NC 41.97 ± 4.29 42.17 ± 4.04 42.09 ± 4.55 41.22 ± 3.14
TPE 43.84 ± 3.44 43.84 ± 3.43 44.53 ± 4.12* 43.91 ± 4.77**
PTPE 44.84 ± 4.36** 43.66 ± 3.77 42.50 ± 2.41@ 43.47 ± 3.51**
MUFA NC 7.60 ± 2.29 6.72 ± 1.54@@ 7.29 ± 2.33 6.82 ± 1.63@
TPE 7.05 ± 1.33 6.79 ± 1.66 6.83 ± 1.49 6.78 ± 1.49
PTPE 7.46 ± 1.82 6.73 ± 1.83 7.85 ± 1.53# 7.26 ± 1.35
CM— central maternal region, CF— central fetal region, PM— peripheral maternal region, PF— peripheral fetal region; NC— normotensive control, TPE— term preeclampsia and PTPE—
preterm preeclampsia; **p b 0.01, *p b 0.05 as comparedwith NC and &&p b 0.01, &p b 0.05 as comparedwith TPE in the corresponding region; @@p b 0.01, @p b 0.05 as comparedwith CM,
##p b 0.01, #p b 0.05 as comparedwith CF and %p b 0.05 as comparedwith PMof the same group; LA— linoleic acid, AA— arachidonic acid, omega 6— total omega 6 fatty acid, ALA— alpha
linolenic acid, DHA— docosahexaenoic acid, omega 3— total omega 3 fatty acid, omega 6:omega 3— total omega 6 fatty acids/total omega 3 fatty acid, SFA— saturated fatty acid, MUFA—
monounsaturated fatty acid; data represented as Mean ± S.D.
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placenta
In the current study, AA levels were higher in the CF region of the
placenta as compared with CM and PM regions in the NC group. A com-
bined analysis of AA and omega 6 fatty acid levels in maternal regions
(Avg of CM & PM) with fetal regions (Avg of CF & PF) indicated that
the levels of these fatty acids were higher in the fetal side as compared
to thematernal side (data not shown) andmay possibly indicate a pref-
erential transfer of LCPUFA from themother to the fetus. It has been re-
ported that placental fatty acid binding and transport proteins (FABPs &
FATPs) preferentially transfer LCPUFA which shifts the concentration
gradient towards the fetal side of the placenta [28,29]. AA is reported
to dominate in the placental phospholipid membranes suggesting an
important role inmaintainingmembrane structure, function, and integ-
rity [30]. Further, its active metabolites like eicosanoids are also
required by the fetus to regulate various metabolic processes [31].
In this study, we have reported lower levels of AA in TPE as well as
PTPE placenta in the fetal regions (CF and PF respectively). Due to this
the concentration gradient of AA from maternal to the fetal side which
was observed in the NC placenta disappeared in PE placenta. The pla-
cental pathology may have altered this gradient in PE through
dysregulation of fatty acid transport and binding proteins.
In this study, DHA and omega 3 fatty acid levels were lower in the CF
region as compared to the PM region of the placenta in the PTPE group.
A combined analysis of omega 3 fatty acid levels in the central regions
(Avg of CM & CF) with the peripheral regions (Avg of PM & PF) (data
not shown) also suggests lower levels in the central region (with
respect to the cord insertion). Reports indicate that the onset of mater-
nal blood ﬂow starts earlier and is higher in the center in the abnormal
placenta than the normal placenta [32]. This has been attributed to
insufﬁcient trophoblastic migration and vascular plugging which
results in abnormally high maternal blood ﬂow affecting the normaldevelopment of the villous tree in the center of the placenta [19]. Such
conditions affect the placental functions by disrupting the nutrient
transport system of the trophoblast cells [33]. Hence, lower omega 3
fatty acidmaybedue to an inefﬁcient fatty acidmetabolism and transfer
in the center of the placenta in PTPE group.
The present study showed highest omega 6:omega 3 fatty acid ratio
in CF region of the placenta as compared to both the peripheral regions
(PM & PF) in PTPE group. Various studies have associated elevated ratio
of omega 6 to omega 3 fatty acids with increased risk of PE [34–36].
Higher proportions of omega 6 fatty acids are known to increase inﬂam-
mation due to excessive formation of inﬂammatory eicosanoids [37]. In
contrast omega 3 fatty acid EPA and DHA form protectins and resolvins
those are known to have anti-inﬂammatory properties [38]. Hence, the
increased ratio of these LCPUFA may contribute to increased inﬂamma-
tion in the center of the placenta.
The pathology of PTPE is known to be more severe than TPE [39]. It
has also been reported that TPE placenta has minimal histopathological
features than the control placenta [40]. However, PTPE histopathology
reports chronic inﬂammatory and placental vasoocclusive lesions [41].
This may explain why regional differences in LCPUFA levels are more
prominent in PTPE placenta than in the TPE placenta in this study.
LCPUFAs are susceptible to peroxidation and its byproduct MDA
forms adduct with proteins and DNA, injuring the cell [42]. Recently
we have reported lower MDA levels in the CF as compared with the
CM region of the PTPE placenta [23]. However, in the current study no
such differences were observed in any of the LCPUFA levels between
these two regions in PTPE placenta.
Our results indicate differential regional fatty acid distribution in the
placenta. Reports suggest that differential placental trophoblast cell pro-
gression and onset of maternal blood are the two main phenomena
which regionally affect the trophoblast differentiation as it is controlled
by the interplay of oxygen tension, transcription factors, hormones,
growth factors, and other signaling molecules [12,43].
Fig. 2. Regionwise alterations in fatty acid levels in the preterm preeclampsia placenta as
comparedwith control; DHA— docosahexaenoic acid, AA— arachidonic acid, n3— omega
3 fatty acids, n6— omega 6 fatty acids; BW— birth weight, CM— central maternal region,
PM — peripheral maternal region, CF— central fetal region, PF — peripheral fetal region.
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preeclampsia placenta
In the current study, ALA levels were higher in both the fetal regions
(CF & PF) of the placenta of PTPE as compared to NC group. However,
DHA levels were lower in the CF region of PTPE placenta as compared
to control. ALA is an essential omega 3 fatty acid and the conversion of
ALA to DHA depends upon the availability of several desaturase and
elongase enzymes [44]. We have reported the presence of desaturase
enzymes in the placenta and its lower expression in PE [7]. The observed
lower DHA levels despite higher precursor ALA levels may indicate
altered biosynthesis in the PTPE placenta.
DHA levels were lower in both the central regions (CM & CF) of the
placenta in PTPE as compared to NC and TPE groups. Similar observa-
tions were seen in the case of omega 3 fatty acid. Essential role of
omega 3 fatty acids especially DHA in fetal brain and retinal develop-
ment is well documented in the literature [45,46]. Omega 3 fatty acids
are not only required for fetal development but also to maintain several
metabolic processes in the placenta [21]. Maximum accretion of DHA
to the fetus has been reported to occur in the third trimester of the
pregnancy [47]. We have extensively demonstrated the importance of
DHA during pregnancy and effects of its reduced levels in pregnancy
disorders [8,48,49].
The levels of SFA were higher in PM and PF regions of the of TPE
and CM and PF regions of the PTPE placenta as compared to NC. Animal
studies have shown high saturated fat diet during pregnancy increases
placental oxidative stress and loss of trophoblast cells [50,51]. Our
recent departmental study has shown increased oxidative stress in all
the regions of the TPE as well as PTPE placenta [23].
4.3. Association of LCPUFA with birth weight and blood pressure
In this study, DHA levels of the PF region were positively associated
with birthweight in the PE group. Similar trendwas also observed in the
whole cohort although not signiﬁcant. Reports indicate that maternal
DHA levels are positively associatedwith birthweight [52–54]. However,
future studies need to examine the possible mechanisms behind the role
of PF region in determining the fetal outcome.
The present study reports positive association between omega 6
fatty acid of the fetal regions (CF and PF) with systolic BP in whole
cohort. Omega 6 fatty acids are known to increase inﬂammation [55].
Inﬂammation may play a signiﬁcant role in the incidence of high
blood pressure [56]. Further, the fetal region of the placenta has been
reported to have higher endothelin-1 receptors which are potent vaso-
constrictors affecting the renal function and blood ﬂow associated with
the pregnancy disorders [57,58].
4.4. Limitations
Consistent with our earlier and other studies, in this study, women
with PE had a higher BMI [7,59]. It is known that obesity increases the
risk of PE [60]. However, in this study it was not possible to compare
obese womenwith orwithout PEwhich is a limitation of the study. Sec-
ondly, the PE women delivering pretermwere not compared with con-
trols of similar gestational age which is another limitation of the study.
5. Conclusion
This study conﬁrms regional differences in fatty acid levels in normal
placenta which is further altered in preeclampsia. Further, it was ob-
served that placenta is more affected in PTPE with greater alterations
in the regional LCPUFA levels as compared with control (Fig. 2). A dis-
turbed fatty acid distribution in the PE placenta in a region speciﬁcman-
ner may have an implication for altered regional placental growth
thereby inﬂuencing fetal development leading to programming for
adult diseases. Further investigations on regional differences in fattyacid transport proteins, binding proteins and desaturase enzymes in
the placenta are needed to explain the differential distribution of fatty
acids observed in this study.Acknowledgements
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